Metformin in the treatment of patients with non-alcoholic steatohepatitis.

Uygun, A; Kadayifci, A; T Isik, A; Ozgurtas, T; Deveci, S; Tuzun, A; Yesilova, Z; Gulsen, M; Dagalp, K

doi:10.1111/j.1365-2036.2004.01888.x

Public

Metformin in the treatment of patients with non-alcoholic steatohepatitis.

Shared by NobleBlocks on Mar 1, 2004 • 12:00 AM UTC

Authors:

A Uygun

A Kadayifci

A T Isik

Abstract

BACKGROUND: Increased insulin resistance is the major pathogenic mechanism in the development of non-alcoholic steatohepatitis. AIM: To investigate the therapeutic effect of metformin, a well-known insulin-sensitizing agent, in the treatment of non-alcoholic steatohepatitis. METHODS: Thirty-six pati...

Discussions